ExLibris header image
SFX Logo
Title: The Evolution of Momordica Cyclic Peptides
Source:

Molecular Biology and Evolution [0737-4038] Mahatmanto, T yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Chen, W. "Optimization of a peptide extraction and LC–MS protocol for quantitative analysis of antimicrobial peptides." Future Science OA 5.1 (2019). Link to Full Text for this item Link to SFX for this item
2. Ji, Y. "In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide." Journal of the American Chemical Society 135.31 (2013): 11623-33. Link to Full Text for this item Link to SFX for this item
3. "Sample Preparation for LC‐MS Bioanalysis of Peptides." Wiley,. 284-303. Link to SFX for this item
4. Qian, Z. "Targeting intracellular protein–protein interactions with cell-permeable cyclic peptides." Current opinion in chemical biology. 38: 80-86. Link to SFX for this item
5. Craik, David J. "Cyclotide biosynthesis." Current opinion in chemical biology 17.4 (2013): 546-54. Link to SFX for this item
6. Panka, David J. "Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells." Molecular cancer 12.1 (2013): 17-17. Link to Full Text for this item Link to SFX for this item
7. Lenos, K. "Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer." Cancer research 72.16 (2012): 4074-4084. Link to SFX for this item
8. Plückthun, F. "Designed Armadillo Repeat Proteins: Library generation, characterization and selection of peptide binders with high specificity." Journal of Molecular Biology 424.1-2 (2012): 68-87. Link to SFX for this item
9. EWALD, C. "A Combined NMR and Computational Approach to Investigate Peptide Binding to a Designed Armadillo Repeat Protein." Journal of Molecular Biology 427.10 (2015): 1916-1933. Link to SFX for this item
10. Rhodes, Curran A. "Bicyclic Peptides as Next-Generation Therapeutics." Chemistry - A European Journal 23.52 (2017): 12690-12703. Link to Full Text for this item Link to SFX for this item
11. Schmidt, M. "Enzyme-mediated ligation technologies for peptides and proteins." Current opinion in chemical biology 38 (2017): 1-7. Link to SFX for this item
12. Scott, Duncan E. "Small molecules, big targets: drug discovery faces the protein-protein interaction challenge." Nature reviews. Drug discovery 15.8 (2016): 533-550. Link to SFX for this item
13. Berlicki, Ł. "Peptide-based inhibitors of protein–protein interactions." Bioorganic and medicinal chemistry letters 26.3 (2016): 707-713. Link to SFX for this item
14. Rowland, Elizabeth F. "Exploring leucine-rich repeat proteins as molecular scaffolds: design of an oxidation-resistant ribonuclease inhibitor." The FASEB journal 2009. Link to SFX for this item
15. Liang, M. "HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis." Modern Pathology 23.3 (2010): 381-391. Link to Full Text for this item Link to SFX for this item
16. Wade, M. "MDM2, MDMX and p53 in oncogenesis and cancer therapy." Nature Reviews. Cancer 13.2 (2013): 83-96. Link to SFX for this item
17. Raboisson, P. "Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350." Bioorganic and medicinal chemistry letters 18.17 (2008): 4853-4858. Link to SFX for this item
18. Ellisen, Leif W. "The molecular pathogenesis of head and neck squamous cell carcinoma." The Journal of clinical investigation 122.6 (2012): 1951-1957. Link to Full Text for this item Link to SFX for this item
19. Buddingh, Emilie P. "Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents." Clinical cancer research 17.8 (2011): 2110-2119. Link to SFX for this item
20. Flp, V. "Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis." Cell 94.2 (1998): 161-170. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced